UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000265 |
|---|---|
| Receipt number | R000000327 |
| Scientific Title | Sequential chemotherapy with FEC(fluoraouracil, epirubicin and cyclophosphamide) and P+H(weekly Paclitaxel+Trastuzumab) as primary systemic therapy for operable breast cancer with HER2 positive disease-a phase 2 study |
| Date of disclosure of the study information | 2005/10/16 |
| Last modified on | 2013/04/16 22:43:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2005/10/16 00:01:54 | ||
| 2 | Update | 2005/10/16 00:03:48 | Acronym Acronym |
|
| 3 | Update | 2008/12/19 18:35:13 | Recruitment status |
|
| 4 | Update | 2012/10/16 23:27:09 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2013/04/16 22:43:40 | Recruitment status Publication of results |
